These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33907349)

  • 1. HIV/AIDS: Current Updates on the Disease, Treatment and Prevention.
    Gupta PK; Saxena A
    Proc Natl Acad Sci India Sect B Biol Sci; 2021; 91(3):495-510. PubMed ID: 33907349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4
    Liu Z; Chen S; Jin X; Wang Q; Yang K; Li C; Xiao Q; Hou P; Liu S; Wu S; Hou W; Xiong Y; Kong C; Zhao X; Wu L; Li C; Sun G; Guo D
    Cell Biosci; 2017; 7():47. PubMed ID: 28904745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic, Selectable, Knock-in Targeting of CCR5
    Scheller SH; Rashad Y; Saleh FM; Willingham KA; Reilich A; Lin D; Izadpanah R; Alt EU; Braun SE
    Front Immunol; 2022; 13():821190. PubMed ID: 35386712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
    Hütter G; Bodor J; Ledger S; Boyd M; Millington M; Tsie M; Symonds G
    Viruses; 2015 Jul; 7(8):4186-203. PubMed ID: 26225991
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Xu M
    Cell Biosci; 2020; 10():48. PubMed ID: 32257106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in chemokine receptors and AIDS.
    Kou J; Kuang YQ
    Prog Mol Biol Transl Sci; 2019; 161():113-124. PubMed ID: 30711024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for HIV-1 suppression through key genes and cell therapy.
    Sorokina A; Anchakova E; Dashinimaev E
    Front Med (Lausanne); 2023; 10():1259995. PubMed ID: 38093984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology.
    Qi C; Li D; Jiang X; Jia X; Lu L; Wang Y; Sun J; Shao Y; Wei M
    Mol Ther Nucleic Acids; 2018 Sep; 12():267-274. PubMed ID: 30195765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation.
    Prator CA; Donatelli J; Henrich TJ
    Curr HIV/AIDS Rep; 2020 Aug; 17(4):385-393. PubMed ID: 32519184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
    Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
    Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303/m303 mutant patient for HIV/AIDS.
    Esmaeilzadeh A; Farshbaf A; Erfanmanesh M
    Med Hypotheses; 2015 Mar; 84(3):216-8. PubMed ID: 25613565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from London and Berlin: Designing A Scalable Gene Therapy Approach for HIV Cure.
    Peterson CW; Kiem HP
    Cell Stem Cell; 2019 May; 24(5):685-687. PubMed ID: 31051132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood transplantation for cure of HIV infections.
    Petz L
    Stem Cells Transl Med; 2013 Sep; 2(9):635-7. PubMed ID: 23884642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?
    Kalidasan V; Theva Das K
    Front Microbiol; 2020; 11():46. PubMed ID: 32082282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of selected or transgenic blood stem cells - a future treatment for HIV/AIDS?
    Hütter G; Schneider T; Thiel E
    J Int AIDS Soc; 2009 Jun; 12():10. PubMed ID: 19558721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.
    Barmania F; Pepper MS
    Appl Transl Genom; 2013 Dec; 2():3-16. PubMed ID: 27942440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.
    Li C; Yan YP; Shieh B; Lee CM; Lin RY; Chen YM
    J Formos Med Assoc; 1997 Dec; 96(12):979-84. PubMed ID: 9444918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection.
    Allen AG; Chung CH; Atkins A; Dampier W; Khalili K; Nonnemacher MR; Wigdahl B
    Front Microbiol; 2018; 9():2940. PubMed ID: 30619107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.
    Li C; Guan X; Du T; Jin W; Wu B; Liu Y; Wang P; Hu B; Griffin GE; Shattock RJ; Hu Q
    J Gen Virol; 2015 Aug; 96(8):2381-2393. PubMed ID: 25854553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.